EPM2A is a gene encoding the protein laforin, which is also known as epilepsy, progressive myoclonic type 2A. Laforin contributes to the removal of abnormal or excess proteins from inside cells. The effects of specific mutations in EPM2A may be difficult to determine because they are not easily measured in cellular models.
Providing modelling and drug screening services for EPM2A can be a complicated process. For this reason, we may be limited in our abilities to provide research services for mutations in this gene at this time. Please contact us with interests and inquiries.